Cargando…
Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case report
BACKGROUND: Usher Syndrome is the commonest cause of inherited blindness and deafness. The condition is clinically and genetically heterogeneous, with no current treatment. We report a case carrying novel biallelic variants in USH2A causing progressive early adolescent onset visual and hearing impai...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962547/ https://www.ncbi.nlm.nih.gov/pubmed/35346118 http://dx.doi.org/10.1186/s12886-022-02353-7 |
_version_ | 1784677825380352000 |
---|---|
author | Young, Su Ling Stanton, Chloe M. Livesey, Benjamin J. Marsh, Joseph A. Cackett, Peter D. |
author_facet | Young, Su Ling Stanton, Chloe M. Livesey, Benjamin J. Marsh, Joseph A. Cackett, Peter D. |
author_sort | Young, Su Ling |
collection | PubMed |
description | BACKGROUND: Usher Syndrome is the commonest cause of inherited blindness and deafness. The condition is clinically and genetically heterogeneous, with no current treatment. We report a case carrying novel biallelic variants in USH2A causing progressive early adolescent onset visual and hearing impairment consistent with Usher Syndrome Type IIA. CASE PRESENTATION: Our patient presented at age 13 with progressive visual field loss and hearing loss, associated with early onset of cataract in her 40s requiring lens extraction. Now 52 years old, latest best corrected visual acuity (BCVA) stands at Logmar Right Eye (RE) 0.8 and Left Eye (LE) 0.2, with significantly constricted visual fields bilaterally. She was registered partially sighted age 46. Clinical and molecular genetic assessment of the proband was consistent with a diagnosis of Usher Syndrome Type IIA. Genetic testing identified two novel USH2A variants, resulting in the premature termination codon p.Leu30Ter and a missense mutation p.Cys3251Tyr. Segregation analysis confirmed that these variants were biallelic in the affected case. Comprehensive in silico analysis confirmed that these mutations are the probable cause of Usher Syndrome Type IIA in this individual. CONCLUSIONS: The identification of novel mutations in USH2A increases the spectrum of genetic variations that lead to Usher Syndrome, aiding genetic diagnosis, assessment of patient prognosis, and emphasising the importance of genetic testing to identify new mutations in patients with undiagnosed progressive visual loss. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12886-022-02353-7. |
format | Online Article Text |
id | pubmed-8962547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89625472022-03-30 Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case report Young, Su Ling Stanton, Chloe M. Livesey, Benjamin J. Marsh, Joseph A. Cackett, Peter D. BMC Ophthalmol Case Report BACKGROUND: Usher Syndrome is the commonest cause of inherited blindness and deafness. The condition is clinically and genetically heterogeneous, with no current treatment. We report a case carrying novel biallelic variants in USH2A causing progressive early adolescent onset visual and hearing impairment consistent with Usher Syndrome Type IIA. CASE PRESENTATION: Our patient presented at age 13 with progressive visual field loss and hearing loss, associated with early onset of cataract in her 40s requiring lens extraction. Now 52 years old, latest best corrected visual acuity (BCVA) stands at Logmar Right Eye (RE) 0.8 and Left Eye (LE) 0.2, with significantly constricted visual fields bilaterally. She was registered partially sighted age 46. Clinical and molecular genetic assessment of the proband was consistent with a diagnosis of Usher Syndrome Type IIA. Genetic testing identified two novel USH2A variants, resulting in the premature termination codon p.Leu30Ter and a missense mutation p.Cys3251Tyr. Segregation analysis confirmed that these variants were biallelic in the affected case. Comprehensive in silico analysis confirmed that these mutations are the probable cause of Usher Syndrome Type IIA in this individual. CONCLUSIONS: The identification of novel mutations in USH2A increases the spectrum of genetic variations that lead to Usher Syndrome, aiding genetic diagnosis, assessment of patient prognosis, and emphasising the importance of genetic testing to identify new mutations in patients with undiagnosed progressive visual loss. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12886-022-02353-7. BioMed Central 2022-03-26 /pmc/articles/PMC8962547/ /pubmed/35346118 http://dx.doi.org/10.1186/s12886-022-02353-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Young, Su Ling Stanton, Chloe M. Livesey, Benjamin J. Marsh, Joseph A. Cackett, Peter D. Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case report |
title | Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case report |
title_full | Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case report |
title_fullStr | Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case report |
title_full_unstemmed | Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case report |
title_short | Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case report |
title_sort | novel biallelic ush2a variants in a patient with usher syndrome type iia- a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962547/ https://www.ncbi.nlm.nih.gov/pubmed/35346118 http://dx.doi.org/10.1186/s12886-022-02353-7 |
work_keys_str_mv | AT youngsuling novelbiallelicush2avariantsinapatientwithushersyndrometypeiiaacasereport AT stantonchloem novelbiallelicush2avariantsinapatientwithushersyndrometypeiiaacasereport AT liveseybenjaminj novelbiallelicush2avariantsinapatientwithushersyndrometypeiiaacasereport AT marshjosepha novelbiallelicush2avariantsinapatientwithushersyndrometypeiiaacasereport AT cackettpeterd novelbiallelicush2avariantsinapatientwithushersyndrometypeiiaacasereport |